$1.2 Billion is the total value of Eversept Partners, LP's 71 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 43.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| QQQ | Sell | INVESCO QQQ TRput | $129,297,000 | -10.5% | 350,000 | -22.2% | 10.81% | +7.3% |
| NTRA | Sell | NATERA INC | $117,454,875 | -25.0% | 2,413,787 | -14.4% | 9.82% | -10.0% |
| Sell | GSK PLCsponsored adr | $103,772,185 | -22.5% | 2,881,012 | -22.8% | 8.68% | -7.1% | |
| SPY | Sell | SPDR S&P 500 ETF TRput | $101,954,400 | -39.3% | 230,000 | -43.9% | 8.52% | -27.2% |
| TEVA | Buy | TEVA PHARMACEUTICAL INDS LTDsponsored ads | $57,740,371 | +5.3% | 7,668,044 | +23.8% | 4.83% | +26.3% |
| UTHR | Buy | UNITED THERAPEUTICS CORP DEL | $57,482,859 | +15.6% | 260,398 | +17.2% | 4.81% | +38.6% |
| HZNP | Sell | HORIZON THERAPEUTICS PUB L | $48,885,634 | -45.3% | 475,310 | -42.0% | 4.09% | -34.4% |
| SNDX | Sell | SYNDAX PHARMACEUTICALS INC | $45,831,091 | -1.8% | 2,189,732 | -0.9% | 3.83% | +17.8% |
| CYH | Sell | COMMUNITY HEALTH SYS INC NEW | $32,022,566 | -28.0% | 7,277,856 | -19.9% | 2.68% | -13.7% |
| TECH | Buy | BIO-TECHNE CORP | $27,969,458 | +99.8% | 342,637 | +81.6% | 2.34% | +139.5% |
| VERA | Sell | VERA THERAPEUTICS INCcl a | $27,942,264 | +101.3% | 1,740,951 | -2.7% | 2.34% | +141.3% |
| INSP | New | INSPIRE MED SYS INC | $26,764,945 | – | 82,445 | +100.0% | 2.24% | – |
| CLDX | Buy | CELLDEX THERAPEUTICS INC NEW | $26,660,158 | +7.4% | 785,740 | +13.9% | 2.23% | +28.8% |
| DHR | Sell | DANAHER CORPORATION | $24,830,205 | -33.8% | 103,345 | -30.5% | 2.08% | -20.6% |
| HCA | Buy | HCA HEALTHCARE INC | $24,498,423 | +232.9% | 80,725 | +189.2% | 2.05% | +299.2% |
| ILMN | Sell | ILLUMINA INC | $23,258,509 | -41.4% | 124,052 | -27.3% | 1.94% | -29.7% |
| ICLR | Sell | ICON PLC | $17,945,845 | +9.4% | 71,726 | -6.6% | 1.50% | +31.1% |
| BCRX | Sell | BIOCRYST PHARMACEUTICALS INC | $16,699,676 | -55.7% | 2,372,113 | -47.5% | 1.40% | -46.9% |
| AMRX | Buy | AMNEAL PHARMACEUTICALS INC | $16,322,278 | +126.6% | 5,265,251 | +1.6% | 1.36% | +171.9% |
| CTLT | Sell | CATALENT INC | $15,474,100 | -58.9% | 356,875 | -37.8% | 1.29% | -50.8% |
| MCRB | Buy | SERES THERAPEUTICS INC | $14,737,661 | +2.5% | 3,076,756 | +21.3% | 1.23% | +22.8% |
| AMRN | New | AMARIN CORP PLCspons adr new | $12,497,510 | – | 10,502,109 | +100.0% | 1.04% | – |
| KRYS | New | KRYSTAL BIOTECH INC | $12,498,991 | – | 106,465 | +100.0% | 1.04% | – |
| ABCM | New | ABCAM PLCads | $12,220,171 | – | 499,394 | +100.0% | 1.02% | – |
| AMN | Buy | AMN HEALTHCARE SVCS INCput | $10,366,400 | +212.4% | 95,000 | +137.5% | 0.87% | +275.3% |
| CNC | Sell | CENTENE CORP DEL | $10,301,841 | -43.5% | 152,733 | -47.0% | 0.86% | -32.3% |
| IONS | Sell | IONIS PHARMACEUTICALS INC | $9,911,699 | -8.6% | 241,572 | -20.4% | 0.83% | +9.7% |
| PCVX | Sell | VAXCYTE INC | $9,772,809 | -12.8% | 195,691 | -34.6% | 0.82% | +4.5% |
| TARO | Buy | TARO PHARMACEUTICAL INDS LTD | $9,493,348 | +59.2% | 250,286 | +2.0% | 0.79% | +90.9% |
| RGEN | Buy | REPLIGEN CORP | $9,345,838 | +881.5% | 66,067 | +1068.1% | 0.78% | +1083.3% |
| IFRX | New | INFLARX NV | $8,541,404 | – | 1,915,113 | +100.0% | 0.71% | – |
| Buy | NEWAMSTERDAM PHARMA COMPANYordinary shares | $8,232,267 | +1253.9% | 692,369 | +1409.9% | 0.69% | +1538.1% | |
| MODN | Sell | MODEL N INC | $7,891,220 | -2.5% | 223,168 | -7.7% | 0.66% | +17.0% |
| XBI | Buy | SPDR SER TRput | $7,488,000 | +22.8% | 90,000 | +12.5% | 0.63% | +47.3% |
| LQDA | Buy | LIQUIDIA CORPORATION | $7,264,735 | +45.1% | 925,444 | +27.8% | 0.61% | +73.9% |
| XENE | Sell | XENON PHARMACEUTICALS INC | $6,598,053 | -9.3% | 171,378 | -15.7% | 0.55% | +8.9% |
| MOH | New | MOLINA HEALTHCARE INC | $6,402,555 | – | 21,254 | +100.0% | 0.54% | – |
| PBYI | Sell | PUMA BIOTECHNOLOGY INC | $5,853,428 | -2.3% | 1,658,195 | -14.4% | 0.49% | +17.0% |
| SWAV | Sell | SHOCKWAVE MED INC | $5,747,587 | -44.3% | 20,138 | -57.7% | 0.48% | -33.1% |
| HUM | Sell | HUMANA INC | $5,343,293 | -51.7% | 11,927 | -47.6% | 0.45% | -42.1% |
| PNTG | Buy | PENNANT GROUP INC | $5,300,318 | -12.0% | 431,622 | +2.3% | 0.44% | +5.5% |
| APLS | New | APELLIS PHARMACEUTICALS INC | $5,142,504 | – | 56,449 | +100.0% | 0.43% | – |
| KURA | New | KURA ONCOLOGY INC | $4,767,581 | – | 450,622 | +100.0% | 0.40% | – |
| IQV | Buy | IQVIA HLDGS INC | $4,213,988 | +47.0% | 18,748 | +30.0% | 0.35% | +76.0% |
| EHTH | Sell | EHEALTH INC | $4,044,755 | -65.0% | 503,079 | -59.2% | 0.34% | -58.1% |
| MEDP | Buy | MEDPACE HLDGS INC | $3,738,006 | +70.4% | 15,564 | +33.4% | 0.31% | +104.6% |
| CVAC | New | CUREVAC N V | $3,723,504 | – | 357,342 | +100.0% | 0.31% | – |
| STRO | New | SUTRO BIOPHARMA INC | $3,477,791 | – | 747,912 | +100.0% | 0.29% | – |
| MRUS | Buy | MERUS N V | $3,455,181 | +45.5% | 131,226 | +1.7% | 0.29% | +74.1% |
| A | Buy | AGILENT TECHNOLOGIES INC | $3,428,719 | +89.1% | 28,460 | +117.1% | 0.29% | +127.8% |
| PTGX | New | PROTAGONIST THERAPEUTICS INC | $3,166,882 | – | 114,659 | +100.0% | 0.26% | – |
| Sell | BIOHAVEN LTD | $3,135,984 | +23.7% | 131,103 | -29.4% | 0.26% | +48.0% | |
| PRTK | Buy | PARATEK PHARMACEUTICALS INC | $2,934,564 | +81.0% | 1,327,857 | +108.0% | 0.24% | +116.8% |
| WAT | New | WATERS CORP | $2,912,749 | – | 10,928 | +100.0% | 0.24% | – |
| PKI | Buy | REVVITY INC | $2,531,890 | +54.0% | 21,314 | +72.8% | 0.21% | +84.3% |
| BDTX | New | BLACK DIAMOND THERAPEUTICS I | $2,157,951 | – | 427,317 | +100.0% | 0.18% | – |
| Sell | GOHEALTH INCcl a new | $2,066,002 | +1.5% | 104,820 | -16.2% | 0.17% | +21.8% | |
| XOMA | XOMA CORP DEL | $1,699,156 | -10.5% | 89,950 | 0.0% | 0.14% | +7.6% | |
| EOLS | Buy | EVOLUS INC | $1,662,496 | -11.3% | 228,679 | +3.2% | 0.14% | +6.1% |
| ARGX | Buy | ARGENX SEsponsored adr | $1,618,938 | +13.3% | 4,154 | +8.3% | 0.14% | +35.0% |
| ZLAB | Sell | ZAI LAB LTDadr | $1,530,030 | -73.3% | 55,176 | -67.9% | 0.13% | -67.9% |
| ANTM | New | ELEVANCE HEALTH INC | $1,028,531 | – | 2,315 | +100.0% | 0.09% | – |
| AFMD | Sell | AFFIMED N V | $1,002,992 | -28.6% | 1,676,684 | -11.0% | 0.08% | -14.3% |
| GOSS | Sell | GOSSAMER BIO INC | $899,636 | -47.2% | 749,697 | -44.6% | 0.08% | -37.0% |
| AVTE | AEROVATE THERAPEUTICS INC | $861,650 | -15.0% | 50,242 | 0.0% | 0.07% | +1.4% | |
| URGN | New | UROGEN PHARMA LTD | $774,149 | – | 74,797 | +100.0% | 0.06% | – |
| AADI BIOSCIENCE INC | $697,119 | -5.5% | 101,918 | 0.0% | 0.06% | +13.7% | ||
| ACIU | AC IMMUNE SA | $368,160 | +26.3% | 124,589 | 0.0% | 0.03% | +55.0% | |
| SBTX | New | ARS PHARMACEUTICALS INC | $326,880 | – | 48,788 | +100.0% | 0.03% | – |
| FGEN | New | FIBROGEN INCput | $104,760 | – | 38,800 | +100.0% | 0.01% | – |
| FGEN | New | FIBROGEN INC | $15,120 | – | 5,600 | +100.0% | 0.00% | – |
| HSKA | Exit | HESKA CORP | $0 | – | -26,409 | -100.0% | -0.18% | – |
| THC | Exit | TENET HEALTHCARE CORP | $0 | – | -141,892 | -100.0% | -0.59% | – |
| Exit | ELEVANCE HEALTH INC | $0 | – | -20,615 | -100.0% | -0.66% | – | |
| GH | Exit | GUARDANT HEALTH INC | $0 | – | -483,098 | -100.0% | -0.79% | – |
| ITCI | Exit | INTRA-CELLULAR THERAPIES INC | $0 | – | -218,726 | -100.0% | -0.83% | – |
| AVTR | Exit | AVANTOR INC | $0 | – | -717,614 | -100.0% | -1.06% | – |
| Exit | AMEDISYS INC | $0 | – | -224,263 | -100.0% | -1.15% | – | |
| Exit | AMARIN CORP PLCspons adr new | $0 | – | -14,612,757 | -100.0% | -1.53% | – | |
| BIIB | Exit | BIOGEN INC | $0 | – | -153,774 | -100.0% | -2.98% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2023-11-08
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMARIN CORP PLC | 21 | Q3 2023 | 12.5% |
| DANAHER CORPORATION | 21 | Q3 2023 | 8.1% |
| AFFIMED N V | 20 | Q3 2023 | 0.9% |
| ARGENX SE | 19 | Q3 2023 | 2.0% |
| GSK PLC | 18 | Q2 2022 | 13.1% |
| ASCENDIS PHARMA A/S | 18 | Q1 2022 | 7.7% |
| SANOFI | 18 | Q4 2022 | 7.2% |
| ENSIGN GROUP INC | 18 | Q1 2022 | 8.6% |
| CENTENE CORP DEL | 18 | Q3 2023 | 1.5% |
| ZOGENIX INC | 17 | Q4 2021 | 12.4% |
View Eversept Partners, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cabaletta Bio, Inc. | February 14, 2023 | 282,874 | 1.0% |
| Teligent, Inc.Sold out | February 16, 2021 | 0 | 0.0% |
| Teligent, Inc. | February 14, 2020 | 4,501,799 | 8.4% |
View Eversept Partners, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
View Eversept Partners, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.